10 Stocks Outperform Broader Market Last Week

3. ImmunityBio Inc. (NASDAQ:IBRX)

Despite a 6.55 percent drop in Friday’s trading, ImmunityBio managed to finish stronger week-on-week, adding 15.9 percent to its valuation at $3.14 versus the $2.71 registered on March 21.

Trading in the company was particularly influenced by its upcoming Investor Day, slated for April 15, 2025, where it is expected to announce in-depth updates about its business operations and recent research and development advancements.

According to the company, key timelines for catalysts of product candidates will be presented, along with a discussion of ongoing clinical trials.

“ImmunityBio commenced 2025 with notable scientific and business milestones. With a promising future ahead, we are eager to engage with our investors and share the reasons we’re optimistic and excited about the company’s growth trajectory,” said IBRX President and CEO Richard Adcock.